综合蛋白转录学方法揭示了针对多药耐药性大肠杆菌的新药标
Manisha Aswal1, Nirpendra Singh2, Neelja Singhal1
1Department of Biophysics, University of Delhi South Campus, New Delhi, India.
Frontiers in microbiology
|March 12, 2025
概括
耐多药性大肠杆菌感染构成了全球性的威胁. 这项研究确定了耐药大肠杆菌中过度表达的关键蛋白质,揭示了具有最小人类副作用的潜在新药标.
科学领域:
- 微生物学 微生物学
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 多药耐药 (MDR) *大肠杆菌*感染导致全球显著的发病率和死亡率.
- 微生物耐药性是一种复杂的特征,受基因组,转录组和蛋白质组因素的影响.
研究的目的:
- 在MDR *E. coli*中识别具有在mRNA和蛋白质水平上差异表达的基因和蛋白质.
- 发现潜在的新型药物标,以对抗大肠杆菌耐药性.
主要方法:
- 综合转录组学 (RNA-Seq) 和蛋白质组学 (SWATH-LC-MS/MS) 分析.
- 生物信息分析包括基因本体学 (GO) 术语,正义基因集群 (COG) 和基因和基因组的京都百科全书 (KEGG) 途径分析.
- 蛋白与蛋白相互作用 (PPI) 网络分析以确定枢纽蛋白.
主要成果:
- 763个基因/蛋白质表现出差异性表达;52个基因在mRNA和蛋白质水平上表现出一致的差异性表达.
- 一致性过度表达的基因参与二次代谢物生物合成,氨基酸tRNA和核糖体.
- 确定了包括smpB,rpsR和topA在内的10个枢纽蛋白,参与翻译和抗生素应激通路. 其中三种缺乏人类同源性.
结论:
- 在MDR *E. coli*中确定了新的药物标,特别是枢纽蛋白 smpB,rpsR 和 topA.
- 这些目标显示出开发具有减少副作用的新抗生素的潜力,原因是缺乏与人类蛋白质的同质性.
- 这项研究提供了一个有希望的策略,用于开发针对耐药和药物敏感*大肠杆菌*菌株的治疗方法.
相关概念视频
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
01:06Carrier-Mediated Transport
227
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
227